Could Cineplex Stock Be a Big Winner in 2023?

Cineplex trades roughly 75% off its pre-pandemic high and is well on its way to recovery this year, making it one of the top stocks to buy.

| More on:
man is enthralled with a movie in a theater

Source: Getty Images

As we saw in the months and years following the start of the pandemic, many stocks eventually recovered from their initial selloff. It wasn’t until uncertainty picked up in 2022 that stocks started to sell off again. However, while most companies eventually recovered from the pandemic’s effects, one company that’s been struggling to recover completely is Cineplex (TSX:CGX) stock.

In 2019, the last full year leading up to the pandemic, Cineplex reported roughly $1.67 billion in revenue. And while restrictions have finally been eased for Cineplex, and it’s back on the right track, over the last four quarters, the company has managed to earn just $1.2 billion, still down roughly 25% from its pre-pandemic levels.

One of the biggest factors that impact Cineplex’s business is the slate of movies coming out of Hollywood, which were also significantly affected by the pandemic. But with many blockbuster films set to hit theatres in 2023, investors are wondering if Cineplex stock could be a big winner in 2023.

Before the pandemic hit, Cineplex stock traded at just under $34 a share. Therefore, with the stock trading below $8.50 as of Wednesday’s close, Cineplex is still down a whopping 75% from its pre-pandemic price.

The company certainly has the potential to recover significantly and rally rapidly as a result. The question will be, can it do so in 2023, when the economy is expected to face major headwinds?

Is Cineplex stock set for a rebound this year?

As I mentioned above, one of the most significant factors impacting Cineplex’s business (and one it has no control over) is the slate of movies it has to offer viewers. And in 2023, many major blockbusters are set to hit theatres, including Barbie, a new Hunger Games movie, Indiana Jones, and at least six major studio superhero movies.

This significant improvement in offerings should help Cineplex to see a major uptick in attendance. Although final numbers for 2022 aren’t in yet, Cineplex is expected to report total attendance of less than 40 million in 2022 — well off the more than 66 million patrons it saw in 2019.

Another positive is that in 2021, and so far through the first three quarters of 2022, Cineplex has been earning more cash per patron, both at the box office and at the concession stand. Therefore, when Cineplex eventually sees a significant rebound in attendance, it should be able to match its 2019 revenue and actually exceed those numbers.

Furthermore, Cineplex’s other businesses, especially its recreation and amusement operations, have been performing exceptionally well over the last few quarters, helping Cineplex to grow its earnings before interest, taxes, depreciation, and amortization (EBITDA) significantly in 2022.

But while Cineplex does have a tonne of potential to continue its recovery, the stock will only be worth an investment if it offers value, especially with all the risk and uncertainty in markets this year.

How much value does Cineplex offer investors today?

Although we know that Cineplex is down roughly 75% from its pre-pandemic price, looking at the chart is just one factor and doesn’t give us enough information to decide if the stock is undervalued today.

It’s far more important to look at several valuation metrics for Cineplex to get a better idea of the value it offers investors.

Before the pandemic, Cineplex traded at a forward enterprise value (EV) to EBITDA ratio of roughly 9.5 times. Today, the stock trades at just 7.1 times its forward EBITDA, showing the stock offers value but isn’t unbelievably cheap.

Keep in mind, though, that as Cineplex continues its recovery, those EBITDA numbers should continue to increase, leading to more upside potential for investors.

Furthermore, typically box office revenues remain flat or even grow through recessions. Therefore, while there is certainly risk in this economic environment, according to historical numbers, Cineplex could continue to perform well through 2023.

And although several analyst target prices have been lowered in recent weeks, as uncertainty grows in the stock market, five of six analysts still rate the stock a buy, and its average analyst target price of $12.41 is almost 50% higher than where Cineplex stock trades today.

Therefore, there’s no question Cineplex stock has the potential to be a big winner in 2023.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned. The Motley Fool recommends Cineplex. The Motley Fool has a disclosure policy.

More on Investing

edit Sale sign, value, discount
Investing

Fire Sale: 2 Cheap TSX Stocks to Buy as the Market Roils

The recent market drop has made these two TSX stocks all the more attractive.

Read more »

Man data analyze
Dividend Stocks

3 Top Dividend Stocks I Can’t Wait to Buy in 2023

Top Dividend Aristocrats are worth buying in almost every market, especially if you hold them long term. However, weak markets…

Read more »

financial freedom sign
Dividend Stocks

Buy 2,911 Shares in This TSX Stock for a Shot at $1 Million in 32 Years

You might not see insane growth overnight, but you won't see insane drops either from this TSX stock offering a…

Read more »

Technology
Dividend Stocks

A Dividend Heavyweight I’d Buy Over Enbridge Right Now

BCE Inc. (TSX:BCE) is a dividend heavyweight I prefer over Enbridge Inc. (TSX:ENB) due to its value and impressive income…

Read more »

stock data
Investing

Better Buy: Aritzia Stock or Canada Goose?

Aritzia stock has notably underperformed Canada Goose in the last five years.

Read more »

sale discount best price
Bank Stocks

3 Dirt-Cheap Bank Stocks to Buy on the Dip

The bout of volatility for global banks has offered up a buying opportunity for bank stocks like Bank of Montreal…

Read more »

edit Close-up Of A Piggybank With Eyeglasses And Calculator On Desk
Bank Stocks

The Best Canadian Bank Stocks to Buy for Your TFSA

The recent decline is a good time to explore and accumulate shares in the big Canadian bank stocks in your…

Read more »

edit U-turn
Investing

1 Dividend-Rich Stock Ready for a Potential Recovery Year

Restaurant Brands International (TSX:QSR) could be ready to roar, whether or not the markets are in for a recovery year.

Read more »